Intervention Review

Anticholinergics for urinary symptoms in multiple sclerosis

  1. Richard S Nicholas1,*,
  2. Tim Friede2,
  3. Sally Hollis3,
  4. Carolyn A Young4

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 29 JAN 2008

DOI: 10.1002/14651858.CD004193.pub2

How to Cite

Nicholas RS, Friede T, Hollis S, Young CA. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004193. DOI: 10.1002/14651858.CD004193.pub2.

Author Information

  1. 1

    Charing Cross Hospital, West London Neurosciences Centre, London, UK

  2. 2

    Warwick Medical School - University of Warwick, Health Sciences Research Institute, Coventry, UK

  3. 3

    University of Nottingham, c/o Cochrane Skin Group, Nottingham, UK

  4. 4

    The Walton Centre for Neurology and Neurosurgery, Liverpool, UK

*Richard S Nicholas, West London Neurosciences Centre, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. richard.nicholas@btinternet.com.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. de Sèze, X. Gamé, Sclérose en plaques et pelvipérinéologie : troubles vésico-sphinctériens, sexuels et maternité, Progrès en Urologie, 2014, 24, 8, 483

    CrossRef

  2. 2
    Ahmed Toosy, Olga Ciccarelli, Alan Thompson, Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  3. 3
    Dirk De Ridder, Frank Van Der Aa, Jan Debruyne, Marie-Beatrice D’hooghe, Benedicte Dubois, Daniel Guillaume, Marco Heerings, Stefan Ilsbroukx, Robert Medaer, Guy Nagels, Pierrette Seeldrayers, William Van Landegem, Barbara Willekens, Anne-Françoise Zicot, Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis, Clinical Neurology and Neurosurgery, 2013, 115, 10, 2033

    CrossRef

  4. 4
    John T. Stoffel, Contemporary Management of the Neurogenic Bladder for Multiple Sclerosis Patients, Urologic Clinics of North America, 2010, 37, 4, 547

    CrossRef

  5. 5
    Anne P. Cameron, Pharmacologic Therapy for the Neurogenic Bladder, Urologic Clinics of North America, 2010, 37, 4, 495

    CrossRef

  6. 6
    Alan J Thompson, Ahmed T Toosy, Olga Ciccarelli, Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions, The Lancet Neurology, 2010, 9, 12, 1182

    CrossRef